Evidence map›Paper›PMID 32206934›Full record

ArticleMikrochimica acta2020

A nanoplatform based on metal-organic frameworks and coupled exonuclease reaction for the fluorimetric determination of T4 polynucleotide kinase activity and inhibition.

Yuying Chai, Xia Cheng, Guanhong Xu, Fangdi Wei, Jian Bao, Jie Mei, Dandan Ren, Qin Hu, Yao Cen

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuying ChaiSchool of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
Xia ChengSchool of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
Guanhong XuSchool of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
Fangdi WeiSchool of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
Jian BaoSchool of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
Jie MeiSchool of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
Dandan RenSchool of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China.
Qin HuSchool of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China. huqin@njmu.edu.cn.ORCID https://orcid.org/0000-0002-4077-8760
Yao CenSchool of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, 211166, People's Republic of China. yaocen@njmu.edu.cn.ORCID https://orcid.org/0000-0002-7829-979X
Nanjing Medical University · CN

Funding

National Natural Science Foundation of China 21705080National Natural Science Foundation of China 61775099National Natural Science Foundation of China 81973283Natural Science Foundation of Jiangsu Province BK20171043Natural Science Foundation of Jiangsu Province BK20171487R&D fund for Smart Health Technology Innovation of Nanjing Medical University and Jiangsu Salt Group No. NMU-SY201801Science and Technology Development Fund of Nanjing Medical University-Major Project NMUD2018004
6 · The paper itself

Abstract

A nanoplatform based on metal-organic frameworks (MOFs) and lambda exonuclease (λ exo) for the fluorimetric determination of T4 polynucleotide kinase (T4 PNK) activity and inhibition is described. Fe-MIL-88 was selected as the nanomaterial because of its significant preferential binding ability to single-stranded DNA (ssDNA) over double-stranded DNA (dsDNA) and its quenching property. The synthesized Fe-MIL-88 was characterized by transmission electron microscope, scanning electron microscope, and X-ray photoelectron spectroscopy. In the presence of T4 PNK, FAM-labeled dsDNA (FAM-dsDNA) is phosphorylated on its 5'-terminal. λ exo then recognizes and cleaves the phosphorylated strand yielding FAM-labeled ssDNA (FAM-ssDNA). The fluorescence of the produced FAM-ssDNA is quenched due to Fe-MIL-88's absorbing on FAM-ssDNA. On the contrary, in the absence of T4 PNK, the phosphorylation and cleavage processes cannot take place. Therefore, the fluorescence of FAM-dsDNA still remains. The fluorescence intensity is detected at the maximum emission wavelength of 524 nm using the maximum excitation wavelength of 488 nm. The assay of T4 PNK based on the fluorescence quenching of FAM-ssDNA achieves a linear relationship in the range 0.01-5.0 U mL

Indexed as

Bacteriophage T4DNA, Single-StrandedEnzyme InhibitorsExonucleasesFluorescenceFluorometryLimit of DetectionMetal-Organic FrameworksNanotechnologyPolynucleotide 5'-Hydroxyl-KinaseDNA, Single-StrandedEnzyme InhibitorsExonucleasesMetal-Organic FrameworksPolynucleotide 5'-Hydroxyl-KinaseCell extractsCoupled enzyme reactionFe-MIL-88Fluorescence assayInhibitor screeningLambda exonucleaseMOFsPreferential binding propertyStatic and dynamic quenchingT4 PNK

Identifiers

PMID32206934
OpenAlexW3012583764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.